玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

VS-5584 (SB2343)

    
99%

VS-5584 (SB2343)

源葉(MedMol)
S80220 一鍵復(fù)制產(chǎn)品信息
1246560-33-7
C17H22N8O
354.41
2-Pyrimidinamine, 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]-
貨號(hào) 規(guī)格 價(jià)格 上海 北京 武漢 南京 購(gòu)買(mǎi)數(shù)量
S80220-5mg 99% ¥340.00 7 - - -
S80220-10mg 99% ¥489.60 7 - - -
S80220-50mg 99% ¥2250.00 貨期:2-3天 - - -
產(chǎn)品介紹 參考文獻(xiàn) 質(zhì)檢證書(shū)(COA) 摩爾濃度計(jì)算器 相關(guān)產(chǎn)品

產(chǎn)品介紹

VS-5584 is a pan-PI3K/mTOR kinase inhibitor with IC50s of 16 nM, 68 nM, 42 nM, 25 nM, and 37 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively. VS-5584 simultaneously blocks mTORC2 as well as mTORC1.

產(chǎn)品描述: VS-5584 is a pan-PI3K/mTOR kinase inhibitor with IC50s of 16 nM, 68 nM, 42 nM, 25 nM, and 37 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively. VS-5584 simultaneously blocks mTORC2 as well as mTORC1.
靶點(diǎn): PI3Kα:16 nM (IC50);PI3Kγ:25 nM (IC50);PI3Kδ:42 nM (IC50);PI3Kβ:68 nM (IC50);Vps34:7470 nM (IC50);mTOR:37 nM (IC50);mTORC1;mTORC2;DNA-PK:1270 nM (IC50);PI3K;mTOR
體內(nèi)研究: Nude mice bearing MDA-MB-231 human breast cancer tumors are treated for 5 days with once daily oral VS-5584 (25 mg/kg). Oral treatment of tumor bearing mice with VS-5584 reduces cancer atem cells analyzed from extracted tumors. Mice are implanted with tumor fragments from a docetaxel-resistant patient-derived triple negative breast cancer. Mice are treated with VS-5584 (20 mg/kg, po, qd) or Docetaxel (20 mg/kg, i.v.). Oral VS-5584 induces tumor regression in a Docetaxel-resistant patient-derived breast cancer model. A single oral dose of VS-5584 is rapidly absorbed with a tmax of 0.9 hours and an elimination half-life of 10 hours. To determine the pharmacokinetic and pharmacodynamic relationship in tumors, PC3-tumor–bearing mice are treated with a single dose of VS-5584 and plasma and tumors are harvested after 6 hours and analyzed for concentrations of VS-5584 and effects on target efficacy biomarkers. Plasma levels of VS-5584 increase dose-dependently. For evaluation of efficacy in a Rapamycin-sensitive PC3 engraftment model, tumor-bearing mice are treated with VS-5584 for 28 days in comparison with the rapalog Everolimus. VS-5584 is well tolerated at both doses tested (11 and 25 mg/kg) with minimal weight loss (mean 4.7% on day 27). Treatment with VS-5584 leads to significant tumor growth inhibition (TGI) of 79% and 113% for 11 and 25 mg/kg, respectively
參考文獻(xiàn): 1. Hart S, et al. VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer. Mol Cancer Ther, 2013, 12(2), 151-161.
溶解性: DMSO  :  33.33  mg/mL  (94.04  mM;  Need  ultrasonic)
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 2.822 ml 14.108 ml 28.216 ml
5 mM 0.564 ml 2.822 ml 5.643 ml
10 mM 0.282 ml 1.411 ml 2.822 ml
50 mM 0.056 ml 0.282 ml 0.564 ml
注意: 部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。

參考文獻(xiàn)

質(zhì)檢證書(shū)(COA)

如何獲取質(zhì)檢證書(shū)(COA)?
請(qǐng)輸入貨號(hào)和一個(gè)與之匹配的批號(hào)。
例如:
批號(hào):JS298415 貨號(hào):S20001-25g
在貨品標(biāo)簽上如何找到貨號(hào)和批號(hào)?

摩爾濃度計(jì)算器

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關(guān)產(chǎn)品

主站蜘蛛池模板: 崇礼县| 灵寿县| 商南县| 开鲁县| 类乌齐县| 丰城市| 大新县| 连州市| 绥滨县| 峨眉山市| 宿迁市| 绩溪县| 贺兰县| 翁牛特旗| 河津市| 乌兰察布市| 甘南县| 屯昌县| 锡林郭勒盟| 佳木斯市| 广灵县| 枞阳县| 商南县| 微博| 谷城县| 元朗区| 栾川县| 佛教| 新余市| 永济市| 习水县| 静安区| 满城县| 本溪| 商洛市| 内黄县| 郯城县| 天峨县| 海安县| 习水县| 平南县|